ticker
Login
business news
Politics And Regulation
Markets
The Economy
Editor's Pick
trading and investing
Stocks
ETFs
Fixed Income
Earnings
Currencies
Commodities
Options
Taxes
Personal Finance
How To Trade
How To Invest
sectors
Biotech/pharma
Consumer
Energy
Financial
Global Markets
Media
Precious Metals
Real Estate
Technology
Transportation
special features
Wall Of Worry
Random Thoughts
Sports Business
Minyanville Press
Video
Hoofy & Boo
Radio
MV PREMIUM
subscriptions
Launch Buzz And Banter
Buzz And Banter
Elliott Wave Insider
Tchir's Fixed Income Report
Cooper's Market Report
Techstrat Report
Optionsmith
The Stock Playbook
Ad Free Minyanville
Minyanville Book Store
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Amgen, Inc.
(NQ:
AMGN
)
104.24
USD
+2.06 (+2.02%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 21, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Amgen, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Amgen Inc. (NASDAQ:AMGN) and BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Added to Equity Profile Report's NASDAQ Gainers Watch List.
Today 16:16 EDT
Wilmington, DE -- (SBWIRE) -- 05/21/2013 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Amgen Inc. (NASDAQ:AMGN) and BioMarin Pharmaceutical Inc. (NASDAQ:BMRN).
Read More
from
SBWire - Latest Press Releases
Is There a Pill For That? Forest Labs’ Iffy Pipeline
Today 9:27 EDT
category
JNJ
,
PJC
,
FRX
, and 1 more.
from
YCharts
Stocks in Focus: Ruckus Wireless Inc (NYSE:RKUS), ADT Corp, Amgen, Inc.(NASDAQ:AMGN) , Safeway Inc
Today 9:17 EDT
Austin, TX -- (SBWIRE) -- 05/21/2013 -- Jackpotpennystocks.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues...
Read More
from
SBWire - Latest Press Releases
New Asthma Drug Generates Excitement For Patients -- And Its Maker
Today 8:52 EDT
Read More
category
NYSE:MRK
,
NYSE:SNY
,
NASDAQ:REGN
, and 1 more.
from
Forbes Real Time
Trading the Setup In Amgen
Today 7:52 EDT
New York, May 21st (TradersHuddle.com) - Amgen Inc. ( NASDAQ:AMGN ) ended the trading session at $102.18, near its 50 day moving average set at $103.39. Amgen's price action placed the stock below this...
Read More
from
TradersHuddle.com
RBCC Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market
Today 5:00 EDT
from
Business Wire News Releases
Lightning Round: CarMax, Asbury Automotive & More
May 20, 2013
Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.
Read More
category
AES Corp
,
Penn National Gaming Inc/
,
MGIC Investment Corp
, and 14 more.
from
CNBC.com News
Dividend Highlights/Lowlights for May 20
May 20, 2013
These were some of the biggest dividend stock performers on the upside and the downside in today’s market action. Highlights Agnico-Eagle Mines (AEM) – up 6% Apple Inc. (AAPL) – up 3% AllianceBernstein...
Read More
category
vz
,
amgn
,
aem
, and 10 more.
from
Dividend Daily
NASDAQ 100 Round Up - Flat: FSLR, CTRP, BIDU
May 20, 2013
New York, May 20th (TradersHuddle.com) - The NASDAQ 100 Index is flat trading at 0, which represents 0% versus its previous close. The index is mixed for the session with slightly less than 50% of its...
Read More
from
TradersHuddle.com
Reference Points for Amgen
May 20, 2013
New York, May 20th (TradersHuddle.com) - Amgen Inc. ( NASDAQ:AMGN ) closed the trading day at $105.63, near its 50 day moving average that is set at $103.20. Amgen's price action is just above this...
Read More
from
TradersHuddle.com
Week in Review: RuiYi Signs Up Shanghai’s Genor to Develop mAb in China
May 18, 2013
RuiYi Inc., a San Diego-Shanghai biotech, signed an exclusive license with Genor BioPharma of Shanghai to develop RuiYi’s lead molecule in China; RuiYi also enlisted CMC Biologics to develop a cell...
Read More
from
ChinaBio® Today
Amgen To Present At The UBS Global Life Sciences Conference
May 16, 2013
from
PR Newswire
How to Play the Building Momentum in Amgen
May 16, 2013
New York, May 16th (TradersHuddle.com) - Shares of Amgen Inc. ( NASDAQ:AMGN ) closed the trading session at $107.42 with its price action in a very tight range, given that calculated support is set at...
Read More
from
TradersHuddle.com
Transgenomic Announces Global Availability of CRC RAScan™ Mutation Detection Test for Use in Patients with Metastatic Colorectal Cancer to Help Identify Appropriate Treatment
May 16, 2013
from
Business Wire News Releases
New Analyses Identify Predictive Biomarkers For Vectibix® (Panitumumab) In Patients With Metastatic Colorectal Cancer
May 15, 2013
Biomarker Analysis From Phase 3 PRIME ('203) Study and Phase 2 PEAK ('509) Study Link Additional RAS Gene Mutations to Vectibix Clinical Response
Read More
from
PR Newswire
Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting
May 15, 2013
from
PR Newswire
Amgen-Zhejiang Beta China JV to Include R&D, Manufacturing
May 15, 2013
Last week, Amgen and Zhejiang Beta Pharma announced they would form a JV to bring Amgen’s biologic drugs to China, starting with Amgen’s colon cancer drug Vectibix. Now, an Amgen spokesperson told...
Read More
from
ChinaBio® Today
Should I Buy Pfizer? 3 Pros, 3 Cons
May 15, 2013
Read More
category
NYSE:MRK
,
Stocks to Buy
,
NYSE:PFE
, and 3 more.
from
InvestorPlace - Latest Headlines
Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest EPS Estimates For The Next Quarter
May 15, 2013
Below are the top biotechnology stocks on the NASDAQ in terms of earnings estimate for the next quarter. Biogen Idec (NASDAQ: BIIB ) is estimated to post earnings of $2.07 per share in the September...
Read More
category
Benzinga
,
Highest EPS Estimates
,
CELG
, and 6 more.
from
Latest Articles from Benzinga.com
Trading Idea: Is Amgen close to Support?
May 14, 2013
New York, May 14th (TradersHuddle.com) - Shares of Amgen Inc. ( NASDAQ:AMGN ) are trading very close to calculated support at $103.85 with price action closing at just $106.89 and placing the stock...
Read More
from
TradersHuddle.com
Amgen (AMGN) - Daily Volume Review
May 14, 2013
NEW YORK (AVAFIN) -- Options traders were heavily trading call contracts during the last ...
Read More
from
AVAFIN
Amgen Is Close to the 50 Day Moving Average
May 13, 2013
New York, May 13th (TradersHuddle.com) - Amgen Inc. ( NASDAQ:AMGN ) closed the trading day at $106.72, near its 50 day moving average that is set at $101.8461. Amgen's price action is just above this...
Read More
from
TradersHuddle.com
RBCC Partner n3D Signs U.S. Distribution Agreement
May 13, 2013
from
Business Wire News Releases
Strategy Behind Our Success, We Get in Early: PSX, AMGN, MPC and BAX
May 11, 2013
from
Marketwired News Releases
Short Interest in Vertex Rises, in Celgene Falls
May 11, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the latter two weeks of April. The number of shares sold short in Dendreon (NASDAQ: DNDN ), Gilead Sciences...
Read More
category
Regeneron Pharmaceuticals
,
amgen
,
Benzinga
, and 35 more.
from
Latest Articles from Benzinga.com
The Week in Review: Sagent Buys Out China JV Partner for $25 Million
May 11, 2013
Sagent Pharma, a US generic injectible drugmaker, will pay $25 million to acquire its partner’s 50% interest in a China manufacturing JV; ScinoPharm Taiwan and Coland Holdings formed a partnership to...
Read More
from
ChinaBio® Today
Ex-Div Reminder for Amgen (AMGN)
May 10, 2013
On 5/14/13, Amgen Inc (AMGN) will trade ex-dividend, for its quarterly dividend of $0.47, payable on 6/7/13. As a percentage of AMGN's recent stock price of $104.54, this dividend works out to...
Read More
category
Dividends
from
Dividend Channel
S&P Highlights Biotech ETFs
May 10, 2013
Bolstered by an accommodating Food & Drug Administration and promising recent clinical results for drugs aimed at treating conditions such as hepatitis C and multiple sclerosis, biotechnology stocks...
Read More
category
Benzinga
,
ETFs
,
PJP
, and 22 more.
from
Latest Articles from Benzinga.com
Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China
May 09, 2013
Amgen (NASDAQ: AMGN ) and Zhejiang Beta Pharma Co., Ltd. (Zhejiang Beta Pharma) today announced that the companies have signed an agreement to form a joint venture to commercialize Amgen's Vectibix®...
Read More
category
Contracts
,
Benzinga
,
AMGN
, and 1 more.
from
Latest Articles from Benzinga.com
Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China
May 09, 2013
Goal Is to Bring Amgen's Vectibix® (Panitumumab) to Chinese Patients
Read More
from
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Stay Connected
WHAT'S POPULAR IN THE VILLE
1
6 Healthy Products That Aren't
Diane Bullock
2
The New Microsoft Xbox One: Key Takeaways (and Red Flags) From Today's Announcement
Jake Barach and Nick Shchteko
3
Gold Mining Stocks: 10 Reasons It's Time to Be Brave
David Banister
4
Random Thoughts: A Signal That Bears Watching
Todd Harrison
5
1929, 1987, and 2013: Three of a Kind?
Jeffrey Cooper
See All Articles
»
Financial Product Guide